Acinar cell NLRP3 inflammasome and gasdermin D (GSDMD) activation mediates pyroptosis and systemic inflammation in acute pancreatitis

Lin Gao,Xiaowu Dong,Weijuan Gong,Wei Huang,Jing Xue,Qingtian Zhu,Nan Ma,Weiwei Chen,Xianghui Fu,Xiang Gao,Zhaoyu Lin,Yanbing Ding,Juanjuan Shi,Zhihui Tong,Tingting Liu,Rajarshi Mukherjee,Robert Sutton,Guotao Lu,Weiqin Li
DOI: https://doi.org/10.1111/bph.15499
IF: 7.3
2021-05-21
British Journal of Pharmacology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Pyroptosis is a lytic form of proinflammatory cell death characterised as caspase‐1‐dependent with canonical NLRP3 inflammasome‐induced gasdermin D (GSDMD) activation. We aimed to investigate the role of acinar pyroptotic cell death in pancreatic injury and systemic inflammation in acute pancreatitis (AP).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>Pancreatic acinar pyroptotic cell death pathway activation upon pancreatic toxin stimulation <i>in vitro</i> and <i>in vivo</i> were investigated. Effects of pharmacological (NLRP3 and caspase‐1 inhibitors), constitutive (<i>Nlrp3</i><sup><i>‐/‐</i></sup><i>, Caspase‐1</i><sup><i>‐/‐</i></sup> and <i>Gsdmd</i><sup><i>‐/‐</i></sup>) and acinar cell conditional (<i>Pdx1</i><sup><i>Cre</i></sup><i>Nlrp3</i><sup><i>Δ/Δ</i></sup> and <i>Pdx1</i><sup><i>Cre</i></sup><i>Gsdmd</i><sup><i>Δ/Δ</i></sup>) genetic inhibition on pyroptotic acinar cell death, pancreatic necrosis and systemic inflammation were assessed using mouse AP models (caerulein, sodium taurocholate, L‐arginine). Effects of <i>Pdx1</i><sup><i>Cre</i></sup><i>Gsdmd</i><sup><i>Δ/Δ</i></sup> vs myeloid conditional knockout (<i>Lyz2</i><sup><i>Cre</i></sup><i>Gsdmd</i><sup><i>Δ/Δ</i></sup>) and <i>Gsdmd</i><sup><i>‐/‐</i></sup> vs receptor interacting protein 3 (RIP3) inhibitor were compared in caerulein‐induced AP (CER‐AP). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>There was consistent pyroptotic acinar cell death upon pancreatic toxin stimulation both <i>in vitro</i> and <i>in vivo</i> which was significantly reduced by pharmacological or genetic pyroptosis inhibition. <i>Pdx1</i><sup><i>Cre</i></sup><i>Gsdmd</i><sup><i>Δ/Δ</i></sup> but not <i>Lyz2</i><sup><i>Cre</i></sup><i>Gsdmd</i><sup><i>Δ/Δ</i></sup> mice significantly reduced pyroptotic acinar cell death, pancreatic necrosis and systemic inflammation in CER‐AP. Co‐application of RIP3 inhibitor on <i>Gsdmd</i><sup><i>‐/‐</i></sup> mice further increased protection on CER‐AP. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>This work demonstrates a critical role for NLRP3 inflammasome and GSDMD activation‐mediated pyroptosis in acinar cells, linking pancreatic necrosis and systemic inflammation in AP. Targeting pyroptosis signalling pathways holds promise for specific AP therapy.</p></section>
pharmacology & pharmacy
What problem does this paper attempt to address?